StockData
Biodexa Pharmaceuticals Plc logo

Biodexa Pharmaceuticals Plc (BDRX) stock

BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 1/30
$2.24−0.16 (-6.67%)

Close on Nov 16, 2026Market cap $5.06MP/E –Yield –

Biodexa Pharmaceuticals EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was -0.00 GBP. The highest annual figure on record is -0.00 GBP in fiscal 2025.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-0.00 GBP–
FY2024Dec 31, 2024-0.00 GBP–
FY2023Dec 31, 2023-0.02 GBP–
FY2022Dec 31, 2022-1.55 GBP–
FY2017Dec 31, 2017-12400.00 GBP–
FY2016Dec 31, 2016-22400.00 GBP–
FY2015Dec 31, 2015-14400.00 GBP–

More Biodexa Pharmaceuticals figures

See a number that looks wrong?